REFERENCES
1. Van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213-28.
2. Bebelman MP, Smit MJ, Pegtel DM, Baglio SR. Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther. 2018;188:1-11.
3. Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracellular Vesicle. 2015;4:27066.
4. Rackles E, Lopez PH, Falcon-Perez JM. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma. Semin Cancer Biol. 2022;87:148-59.
5. Picatoste B, Guaman HM, Herrero-Matesanz M, Piñeres LV, Benito-Martin A. Extracellular vesicles and the lipid messengers: the adipose tissue connection to cancer and metabolic disease. Semin Cancer Biol. 2025;116:59-68.
6. Moraes JA, Encarnação C, Franco VA, et al. Adipose tissue-derived extracellular vesicles and the tumor microenvironment: revisiting the hallmarks of cancer. Cancers. 2021;13:3328.
7. Bouche C, Quail DF. Fueling the tumor microenvironment with cancer-associated adipocytes. Cancer Res. 2023;83:1170-2.
8. Torres N, Vargas-castillo A, Tovar A. Adipose tissue: white adipose tissue structure and function. Encyclopedia of food and health. Elsevier; 2016. pp. 35-42.
9. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2007;60:329-39.
10. Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20:433-47.
11. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19:1252-63.
12. Agustsson T, Rydén M, Hoffstedt J, et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007;67:5531-7.
13. Kliewer KL, Ke J, Tian M, Cole RM, Andridge RR, Belury MA. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol Ther. 2014;16:886-97.
14. Kir S, White JP, Kleiner S, et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014;513:100-4.
15. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518-25.
16. Cohen P, Spiegelman BM. Brown and beige fat: molecular parts of a thermogenic machine. Diabetes. 2015;64:2346-51.
17. Lengyel E, Makowski L, Digiovanni J, Kolonin MG. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends in Cancer. 2018;4:374-84.
18. Sun D, Ding Z, Shen L, Yang F, Han J, Wu G. miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients. Lipids Health Dis. 2021;20:115.
19. Liu Y, Wang M, Deng T, et al. Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ. Cancer Biol Med. 2022:1-14.
20. Liu A, Pan W, Zhuang S, Tang Y, Zhang H. Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. Adipocyte. 2022;11:487-500.
21. Lazar I, Clement E, Dauvillier S, et al. Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer. Cancer Res. 2016;76:4051-7.
22. Clement E, Lazar I, Attané C, et al. Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells. EMBO J. 2020;39:EMBJ2019102525.
23. Liu S, Benito-Martin A, Pelissier Vatter FA, et al. Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism. EMBO Rep. 2023;24:EMBR202357339.
24. Liu Y, Tan J, Ou S, Chen J, Chen L. Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis. J Physiol Biochem. 2019;75:391-401.
25. Wang J, Wu Y, Guo J, Fei X, Yu L, Ma S. Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells. Oncotarget. 2017;8:81880-91.
26. Ramos-andrade I, Moraes J, Brandão-costa RM, et al. Obese adipose tissue extracellular vesicles raise breast cancer cell malignancy. Endocr-Relat Cancer. 2020;27:571-82.
27. Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455-65.
28. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology. 2011;12:489-95.
29. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.
30. Escrevente C, Keller S, Altevogt P, Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer. 2011;11:108.
31. Poças J, Marques C, Gomes C, et al. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival. Proc. Natl. Acad. Sci. U.S.A. 2023;120:e2214853120.
32. Williams C, Pazos R, Royo F, et al. Assessing the role of surface glycans of extracellular vesicles on cellular uptake. Sci Rep. 2019;9:11920.
33. Wang L, Chen X, Meng F, et al. α2,6-Sialylation promotes hepatocellular carcinoma cells migration and invasion via enhancement of nSmase2-mediated exosomal miRNA sorting. J Physiol Biochem. 2022;79:19-34.
34. Wang L, Chen X, Wang L, et al. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects. IUBMB Life. 2021;73:1378-91.
35. Zhang Q, Higginbotham JN, Jeppesen DK, et al. Transfer of functional cargo in exomeres. Cell Reports. 2019;27:940-954.e6.
36. Reis CA. ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front Biosci. 2011;E3:1443-55.
37. Freitas D, Campos D, Gomes J, et al. O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype. EBioMedicine. 2019;40:349-62.
38. Pinho S, Marcos NT, Ferreira B, et al. Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells. Cancer Lett. 2007;249:157-70.
39. Tamura F, Sato Y, Hirakawa M, et al. RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells. Gastric Cancer. 2014;19:85-97.
40. Nakagoe T, Sawai T, Tsuji T, et al. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients. Anticancer Res. 2002;22:451-8.
41. Kakeji Y, Maehara Y, Morita M, et al. Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma. Br J Cancer. 1995;71:191-5.
42. Ozaki H, Matsuzaki H, Ando H, et al. Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model. Clin Exp Metastasis. 2012;29:229-38.
43. Rajesh C, Radhakrishnan P. The (Sialyl) Tn antigen: contributions to immunosuppression in gastrointestinal cancers. Front. Oncol. 2023;12:1093496.
44. Terashima S, Takano Y, Ohori T, et al. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer. Surg Today. 1998;28:682-6.
45. Nakagoe T, Sawai T, Tsuji T, et al. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer. EJSO-Eur J Surg Onc. 2001;27:731-9.
46. Takahashi I, Maehara Y, Kusumoto T, et al. Predictive value of preoperative serum sialyl tn antigen levels in prognosis of patients with gastric cancer. Cancer. 1993;72:1836-40.
47. Maeda K, Chung Y, Onoda N, et al. Serum sialyl-Tn antigen level as a prognostic indicator in patients with gastric-cancer. Int J Oncol. 1994;4:129-32.
48. Ma XC, Terata N, Kodama M, Jancic S, Hosokawa Y, Hattori T. Expression of sialyl-Tn antigen is correlated with survival time of patients with gastric carcinomas. Eur J Cancer. 1993;29:1820-3.
49. Lugo R, Ávila-Nava A, García-Pérez R, Herrera-Escalante S, De La Cruz-Acosta J, Gutiérrez-Solis AL. Systematic review and meta-analysis of the clinical survival significance of sialyl-Tn expression in histological tissues from cancer patients. Transl Cancer Res TCR. 2020;9:547-55.
50. Freitas D, Balmaña M, Poças J, et al. Different isolation approaches lead to diverse glycosylated extracellular vesicle populations. J Extracell Vesicles. 2019;8:1621131.
51. Marcos NT, Pinho S, Grandela C, et al. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res. 2004;64:7050-7.
52. Martins ÁM, Lopes TM, Diniz F, et al. Differential protein and glycan packaging into extracellular vesicles in response to 3D gastric cancer cellular organization. Adv Sci. 2023;10:2300588.
53. Hernandez P, Rackles E, Alboniga OE, et al. Metabolic profiling of brain tissue and brain-derived extracellular vesicles in Alzheimer’s disease. J Extracell Vesicles. 2025;14:e70043.
54. Schymanski EL, Jeon J, Gulde R, et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol. 2014;48:2097-8.
55. Dumas J, Brisson L. Interaction between adipose tissue and cancer cells: role for cancer progression. Cancer Metastasis Rev. 2020;40:31-46.
56. Mukherjee A, Bilecz AJ, Lengyel E. The adipocyte microenvironment and cancer. Cancer Metastasis Rev. 2022;41:575-87.
57. Kir S, Spiegelman BM. Cachexia and brown fat: a burning issue in cancer. Trends in Cancer. 2016;2:461-3.
58. Ni J, Zhang L. Cancer cachexia: definition, staging, and emerging treatments. Cancer Manag Res. 2020;12:5597-605.
59. Shang J, Zhu J, Bai L, et al. Adipocytes impact on gastric cancer progression: prognostic insights and molecular features. World J Gastrointest Oncol. 2024;16:3011-31.
60. Tan Y, Lin K, Zhao Y, et al. Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming. Theranostics. 2018;8:5452-68.
61. Hamabe-Boriike T, Harada SI, Yoshida K, Kinoshita J, Yamaguchi T, Fushida S. Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts. Cancer Rep. 2022;6:e1647.
62. Matsuoka T, Yashiro M. Molecular mechanism for malignant progression of gastric cancer within the tumor microenvironment. Int J Mol Sci. 2024;25:11735.
63. Phuyal S, Hessvik NP, Skotland T, Sandvig K, Llorente A. Regulation of exosome release by glycosphingolipids and flotillins. The FEBS Journal. 2014;281:2214-27.
64. Ghossoub R, Chéry M, Audebert S, et al. Tetraspanin-6 negatively regulates exosome production. Proc. Natl. Acad. Sci. U.S.A. 2020;117:5913-22.
65. Roucourt B, Meeussen S, Bao J, Zimmermann P, David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 2015;25:412-28.
66. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677-85.
67. Nagao K, Maeda K, Hosomi K, Morioka K, Inuzuka T, Ohtsubo K. Sialyl-Tn antigen facilitates extracellular vesicle-mediated transfer of FAK and enhances motility of recipient cells. J Biochem. 2022;171:543-54.
68. Shibata C, Otsuka M, Seimiya T, Kishikawa T, Ishigaki K, Fujishiro M. Lipolysis by pancreatic cancer-derived extracellular vesicles in cancer-associated cachexia via specific integrins. Clin Transl Med. 2022;12:e1089.
69. Wang S, Xu M, Xiao X, et al. Pancreatic cancer cell exosomes induce lipidomics changes in adipocytes. Adipocyte. 2022;11:346-55.
70. Williams J, Camarda R, Malkov S, et al. Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis. Nat Commun. 2025;16:7438.
71. Hu W, Xiong H, Ru Z, et al. Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia. Cell Death Dis. 2021;12:134.
72. Giannitti G, Kamińska K, Marchesi S, et al. Extracellular vesicles released from prostate cancer cells confer pro-tumor properties to adipocytes by stimulating lipolysis. Biofactors. 2025;51:e70067.
73. Sagar G, Sah RP, Javeed N, et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut. 2016;65:1165-74.
74. Hu Y, Liu L, Chen Y, et al. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. Nat Commun. 2023;14:5179.
75. Sun S, Wang Z, Yao F, et al. Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss. Hum Mol Genet. 2023;32:2219-28.
76. Zhao D, Wu K, Sharma S, et al. Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nat Commun. 2022;13:7734.
77. Di W, Zhang W, Zhu B, Li X, Tang Q, Zhou Y. Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR-146b-5p. J Cell Physiol. 2020;236:5399-410.
78. Hu W, Ru Z, Zhou Y, et al. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway. BBA - Mol Cell Biol Lipids. 2019;1864:1091-102.
79. Xiong H, Ye J, Luo Q, Li W, Xu N, Yang H. Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. Cell Signal. 2023;112:110901.
80. Xiong H, Ye J, Xie K, Hu W, Xu N, Yang H. Exosomal IL-8 derived from lung cancer and colon cancer cells induced adipocyte atrophy via NF-κB signaling pathway. Lipids Health Dis. 2022;21:147.
82. Rupert JE, Narasimhan A, Jengelley DH, et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J Exp Med. 2021;218:e20190450.
83. Fang R, Yan L, Liao Z. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Front. Oncol. 2023;13:1123567.
85. Nguyen TD, Miyatake Y, Yoshida T, Kawahara H, Hanayama R. Tumor-secreted proliferin-1 regulates adipogenesis and lipolysis in cachexia. Int J Cancer. 2020;148:1982-92.
86. Wen Y, Xing X, Harris JW, et al. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 2017;8:e2593.
87. Wang YY, Attané C, Milhas D, et al. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight. 2017;2:e87489.
88. Ross FA, Mackintosh C, Hardie DG. AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours. The FEBS Journal. 2016;283:2987-3001.
89. Schlaepfer IR, Glodé LM, Hitz CA, et al. Inhibition of lipid oxidation increases glucose metabolism and enhances 2-deoxy-2-[18F]fluoro-d-glucose uptake in prostate cancer mouse xenografts. Mol Imaging Biol. 2015;17:529-38.
90. Parsons WH, Kolar MJ, Kamat SS, et al. AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs. Nat Chem Biol. 2016;12:367-72.
91. Erikci Ertunc M, Kok BP, Parsons WH, et al. AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice. J Biol Chem. 2020;295:5891-905.
92. Pucer A, Brglez V, Payré C, Pungerčar J, Lambeau G, Petan T. Group X secreted phospholipase A2 induces lipid droplet formation and prolongs breast cancer cell survival. Mol Cancer. 2013;12:111.
94. Astudillo AM, Balboa MA, Balsinde J. Selectivity of phospholipid hydrolysis by phospholipase A2 enzymes in activated cells leading to polyunsaturated fatty acid mobilization. BBA - Mol Cell Biol Lipids. 2019;1864:772-83.
95. Tiwary S, Morales JE, Kwiatkowski SC, Lang FF, Rao G, Mccarty JH. Metastatic brain tumors disrupt the blood-brain barrier and alter lipid metabolism by inhibiting expression of the endothelial cell fatty acid transporter Mfsd2a. Sci Rep. 2018;8:8267.
96. Bjørklund SS, Kristensen VN, Seiler M, et al. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas. BMC Cancer. 2015;15:524.
97. Apaya MK, Hsiao P, Yang Y, Shyur L. Deregulating the CYP2C19/epoxy-eicosatrienoic acid-associated FABP4/FABP5 signaling network as a therapeutic approach for metastatic triple-negative breast cancer. Cancers. 2020;12:199.
98. Apaya MK, Shiau J, Liao G, et al. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer. J Exp Clin Cancer Res. 2019;38:187.
99. Daquinag AC, Gao Z, Fussell C, et al. Fatty acid mobilization from adipose tissue is mediated by CD36 posttranslational modifications and intracellular trafficking. JCI Insight. 2021;6:e147057.
100. Ring A, Le Lay S, Pohl J, Verkade P, Stremmel W. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. BBA - Mol Cell Biol Lipids. 2006;1761:416-23.
101. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498-503.
102. Mukherjee A, Chiang C, Daifotis HA, et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 2020;80:1748-61.
103. Dai W, Luo W, Fang H, et al. Cancer-associated adipocytes promote peritoneal metastasis of colorectal signet ring cell carcinoma via FABP4 induction. Cell Commun Signal. 2025;24:29.
104. Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37:2285-301.
105. Chocarro-Calvo A, Jociles-Ortega M, García-Martinez JM, et al. Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. Genes Dev. 2025;39:463-89.
106. La Camera G, Gelsomino L, Malivindi R, et al. Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity. Cancer Lett. 2021;521:155-68.
107. Cavaleri MP, Pusceddu T, Sileo L, et al. When fat talks: how adipose-derived extracellular vesicles fuel breast cancer. Int J Mol Sci. 2025;26:9666.
108. Giannitti G, Marchesi S, Garavaglia R, et al. Adipocyte-derived extracellular vesicles endow melanoma cells with stem-like traits via PGC-1α-mediated mitochondrial reprogramming. Antioxidants. 2026;15:333.
109. Haque PS, Paris SL, Souza RF, et al. Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis. Cancer Lett. 2025;635:218104.
110. Noda K, Sato Y, Okada Y, et al. Exosomal miR-199a-3p secreted from cancer-associated adipocytes promotes pancreatic cancer progression. Cancer Medicine. 2024;13:e70265.
111. Sun Z, Sun D, Feng Y, et al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Molecular Therapy - Nucleic Acids. 2021;26:253-68.
112. Fontana F, Anselmi M, Carollo E, et al. Adipocyte-derived extracellular vesicles promote prostate cancer cell aggressiveness by enabling multiple phenotypic and metabolic changes. Cells. 2022;11:2388.
113. Yin H, Qiu X, Shan Y, et al. HIF-1α downregulation of miR-433-3p in adipocyte-derived exosomes contributes to NPC progression via targeting SCD1. Cancer Sci. 2021;112:1457-70.
114. Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem. 2013;383:13-20.
115. Wang S, Su X, Xu M, et al. Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway. Stem Cell Res Ther. 2019;10:117.
116. Gelsomino L, Del Console P, Murfuni M, et al. Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment. Int J Oncol. 2025;67:1-18.
117. Liu Q, Sun Y, Fei Z, et al. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells. Acta Biochim Biophys Sin. 2019;51:707-14.
118. Blanquer-rosselló MDM, Oliver J, Sastre-serra J, Valle A, Roca P. Leptin regulates energy metabolism in MCF-7 breast cancer cells. Int J Biochem Cell Biol.2016;72:18-26.
119. Tan Z, Deme P, Boyapati K, et al. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer. Breast Cancer Res. 2023;25:148.
120. Zhou P, Zhu D, Chen Y, et al. High patatin like phospholipase domain containing 8 expression as a biomarker for poor prognosis of colorectal cancer. World J Gastrointest Oncol. 2024;16:787-97.
121. Ježek J, Dlasková A, Zelenka J, Jabůrek M, Ježek P. H2O2- iactivated mitochondrial phospholpase iPLA2γ prevents lipotoxic oxidative stress in synergy with UCP2, amplifies signaling via G-protein-coupled receptor GPR40, and regulates insulin secretion in pancreatic β-cells. Antioxid Redox Signaling. 2015;23:958-72.
122. Jabůrek M, Průchová P, Holendová B, Galkin A, Ježek P. Antioxidant synergy of mitochondrial phospholipase PNPLA8/iPLA2γ with fatty acid-conducting SLC25 gene family transporters. Antioxidants. 2021;10:678.
123. Jiang D, Lagory EL, Kenzelmann Brož D, et al. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Rep. 2015;10:1096-109.
124. Zhao J, Zhou X, Chen B, et al. p53 promotes peroxisomal fatty acid β-oxidation to repress purine biosynthesis and mediate tumor suppression. Cell Death Dis. 2023;14:87.
125. Giordano C, Gelsomino L, Barone I, et al. Leptin modulates exosome biogenesis in breast cancer cells: an additional mechanism in cell-to-cell communication. JCM. 2019;8:1027.
126. Hu W, Ru Z, Xiao W, et al. Adipose tissue browning in cancer-associated cachexia can be attenuated by inhibition of exosome generation. Biochem Biophys Res Commun. 2018;506:122-9.
127. Liu Z, Xiong J, Gao S, et al. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. J cachexia sarcopenia muscle. 2021;13:636-47.
128. Fan M, Gu X, Zhang W, et al. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles. J cachexia sarcopenia muscle. 2022;13:2724-39.
129. Tiash S, Russo M, Pai Y, et al. Immune cells regulate circulating adipocyte extracellular vesicle levels in response to metabolic shifts. Physiology 2025.
